Tubeless percutaneous nephrolithotomy: is it really less morbid?

Area of Science:

• Urology
• Nephrolithiasis Management
• Minimally Invasive Surgery

Background:

• Percutaneous nephrolithotomy (PCNL) is a standard treatment for kidney stones.
• The use of a nephrostomy tube in PCNL can lead to increased morbidity.
• Evaluating
• tubeless
• PCNL is crucial for optimizing patient outcomes.

Purpose of the Study:

• To compare the safety and effectiveness of tubeless PCNL versus standard PCNL.
• To evaluate postoperative pain, analgesia requirements, and hospital stay.
• To determine the impact on return to work time and overall patient morbidity.

Main Methods:

• Prospective evaluation of 60 patients undergoing PCNL.
• Randomization to either tubeless PCNL (with Double-J stent) or standard PCNL (with nephrostomy tube).
• Systematic recording and analysis of pain scores, analgesia use, hospital stay, and return to activity.

Main Results:

• No significant differences in age, stone burden, or baseline laboratory values between groups.
• Tubeless PCNL showed significantly lower operative time, analgesia requirement, and hospital stay (P < 0.001).
• Patients in the tubeless PCNL group returned to normal activities significantly earlier (P < 0.001).

Conclusions:

• Tubeless PCNL is associated with significantly less pain and lower analgesia requirements.
• Shorter hospital stays and earlier return to normal activities are key benefits of the tubeless approach.
• Tubeless PCNL is a secure, effective, and less morbid option for selected patients with nephrolithiasis.